Van Hecke, Kristof

Link to this page

Authority KeyName Variants
85a29275-7aca-45cf-9eba-4570ca920cd4
  • Van Hecke, Kristof (8)
Projects

Author's Bibliography

Antitumor activity of organoruthenium complexes with chelate aromatic ligands, derived from 1,10-phenantroline: Synthesis and biological activity

Savić, Aleksandar; Gligorijević, Nevenka; Aranđelović, Sandra; Dojčinović, Biljana P.; Kaczmarek, Anna M.; Radulović, Siniša; Van Deun, Rik; Van Hecke, Kristof

(Elsevier, 2020)

TY  - JOUR
AU  - Savić, Aleksandar
AU  - Gligorijević, Nevenka
AU  - Aranđelović, Sandra
AU  - Dojčinović, Biljana P.
AU  - Kaczmarek, Anna M.
AU  - Radulović, Siniša
AU  - Van Deun, Rik
AU  - Van Hecke, Kristof
PY  - 2020
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/3781
AB  - The monocationic chloro complexes containing chelating N∩N ligands: [(η6-p-cymene)Ru(L1–4)Cl]+ (1–4), where L1 = 4-methyl-1,10-phenantroline, L2 = dipyrido[3,2-a:2′,3′-c]phenazine, L3 = 11-chloro-dipyrido[3,2-a:2′,3′-c]phenazine, L4 = 11-nitro-dipyrido[3,2-a:2′,3′-c]phenazine; p-cymene = 1-methyl-4-isopropylbenzene) have been prepared and characterized as the hexafluorophosphate salts. The biological activity of 1–4 has been investigated in selected 2D monolayer cell cultures (A549, PANC-1, MDA-MB-231, MRC-5). All investigated ruthenium complexes showed similar or even better cytotoxicity to cisplatin. However, there was no significant reduction in growth of PANC-1 cells in a 3D cell culture of multicellular tumor spheroids (MCTS) after treatment with 2–4, while the cisplatin treatment induced retardation in MCTS growth. Flow cytometry analysis of the cell cycle of PANC-1 cells shows that 3 caused changes of cell cycle phase distribution characterized by slight accumulation of cells in the G2-M phase. Absence of the Sub-G1 phase in the cell cycle of the treated cells indicated that there was no fragmentation of DNA for the analyzed time intervals (48 and 72 h treatment). Fluorescent microscopy, after acridine orange/ethidium bromide staining, revealed that the investigated ruthenium complexes induced some characteristics of apoptotic morphology (shrinking and condensation of chromatin) with notably preserved integrity of the plasma membrane. Investigation of cellular uptake and DNA - fraction accumulation performed by inductively coupled plasma mass spectrometry in PANC-1 cells with equimolar concentrations (5 μM) of 2–4 and cisplatin showed more efficient cellular uptake and DNA - fraction accumulation of complex 3 compared to complexes 2 and 4.
PB  - Elsevier
T2  - Journal of Inorganic Biochemistry
T1  - Antitumor activity of organoruthenium complexes with chelate aromatic ligands, derived from 1,10-phenantroline: Synthesis and biological activity
VL  - 202
SP  - 110869
DO  - 10.1016/j.jinorgbio.2019.110869
ER  - 
@article{
author = "Savić, Aleksandar and Gligorijević, Nevenka and Aranđelović, Sandra and Dojčinović, Biljana P. and Kaczmarek, Anna M. and Radulović, Siniša and Van Deun, Rik and Van Hecke, Kristof",
year = "2020",
abstract = "The monocationic chloro complexes containing chelating N∩N ligands: [(η6-p-cymene)Ru(L1–4)Cl]+ (1–4), where L1 = 4-methyl-1,10-phenantroline, L2 = dipyrido[3,2-a:2′,3′-c]phenazine, L3 = 11-chloro-dipyrido[3,2-a:2′,3′-c]phenazine, L4 = 11-nitro-dipyrido[3,2-a:2′,3′-c]phenazine; p-cymene = 1-methyl-4-isopropylbenzene) have been prepared and characterized as the hexafluorophosphate salts. The biological activity of 1–4 has been investigated in selected 2D monolayer cell cultures (A549, PANC-1, MDA-MB-231, MRC-5). All investigated ruthenium complexes showed similar or even better cytotoxicity to cisplatin. However, there was no significant reduction in growth of PANC-1 cells in a 3D cell culture of multicellular tumor spheroids (MCTS) after treatment with 2–4, while the cisplatin treatment induced retardation in MCTS growth. Flow cytometry analysis of the cell cycle of PANC-1 cells shows that 3 caused changes of cell cycle phase distribution characterized by slight accumulation of cells in the G2-M phase. Absence of the Sub-G1 phase in the cell cycle of the treated cells indicated that there was no fragmentation of DNA for the analyzed time intervals (48 and 72 h treatment). Fluorescent microscopy, after acridine orange/ethidium bromide staining, revealed that the investigated ruthenium complexes induced some characteristics of apoptotic morphology (shrinking and condensation of chromatin) with notably preserved integrity of the plasma membrane. Investigation of cellular uptake and DNA - fraction accumulation performed by inductively coupled plasma mass spectrometry in PANC-1 cells with equimolar concentrations (5 μM) of 2–4 and cisplatin showed more efficient cellular uptake and DNA - fraction accumulation of complex 3 compared to complexes 2 and 4.",
publisher = "Elsevier",
journal = "Journal of Inorganic Biochemistry",
title = "Antitumor activity of organoruthenium complexes with chelate aromatic ligands, derived from 1,10-phenantroline: Synthesis and biological activity",
volume = "202",
pages = "110869",
doi = "10.1016/j.jinorgbio.2019.110869"
}
Savić, A., Gligorijević, N., Aranđelović, S., Dojčinović, B. P., Kaczmarek, A. M., Radulović, S., Van Deun, R.,& Van Hecke, K.. (2020). Antitumor activity of organoruthenium complexes with chelate aromatic ligands, derived from 1,10-phenantroline: Synthesis and biological activity. in Journal of Inorganic Biochemistry
Elsevier., 202, 110869.
https://doi.org/10.1016/j.jinorgbio.2019.110869
Savić A, Gligorijević N, Aranđelović S, Dojčinović BP, Kaczmarek AM, Radulović S, Van Deun R, Van Hecke K. Antitumor activity of organoruthenium complexes with chelate aromatic ligands, derived from 1,10-phenantroline: Synthesis and biological activity. in Journal of Inorganic Biochemistry. 2020;202:110869.
doi:10.1016/j.jinorgbio.2019.110869 .
Savić, Aleksandar, Gligorijević, Nevenka, Aranđelović, Sandra, Dojčinović, Biljana P., Kaczmarek, Anna M., Radulović, Siniša, Van Deun, Rik, Van Hecke, Kristof, "Antitumor activity of organoruthenium complexes with chelate aromatic ligands, derived from 1,10-phenantroline: Synthesis and biological activity" in Journal of Inorganic Biochemistry, 202 (2020):110869,
https://doi.org/10.1016/j.jinorgbio.2019.110869 . .
1
18
6
17
17

DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2',3'-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction

Savić, Aleksandar; Kaczmarek, Anna M.; Van Deun, Rik; Van Hecke, Kristof

(2020)

TY  - JOUR
AU  - Savić, Aleksandar
AU  - Kaczmarek, Anna M.
AU  - Van Deun, Rik
AU  - Van Hecke, Kristof
PY  - 2020
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/4289
AB  - In order to create near-infrared (NIR) luminescent lanthanide complexes suitable for DNA-interaction, novel lanthanide dppz complexes with general formula [Ln(NO3)3(dppz)2] (Ln = Nd3+, Er3+ and Yb3+; dppz = dipyrido[3,2-a:2',3'-c]phenazine) were synthesized, characterized and their luminescence properties were investigated. In addition, analogous compounds with other lanthanide ions (Ln = Ce3+, Pr3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Tm3+, Lu3+) were prepared. All complexes were characterized by IR spectroscopy and elemental analysis. Single-crystal X-ray diffraction analysis of the complexes (Ln = La3+, Ce3+, Pr3+, Nd3+, Eu3+, Er3+, Yb3+, Lu3+) showed that the lanthanide's first coordination sphere can be described as a bicapped dodecahedron, made up of two bidentate dppz ligands and three bidentate-coordinating nitrate anions. Efficient energy transfer was observed from the dppz ligand to the lanthanide ion (Nd3+, Er3+ and Yb3+), while relatively high luminescence lifetimes were detected for these complexes. In their excitation spectra, the maximum of the strong broad band is located at around 385 nm and this wavelength was further used for excitation of the chosen complexes. In their emission spectra, the following characteristic NIR emission peaks were observed: for a) Nd3+: 4F3/2 → 4I9/2 (870.8 nm), 4F3/2 → 4I11/2 (1052.7 nm) and 4F3/2 → 4I13/2 (1334.5 nm); b) Er3+: 4I13/2 → 4I15/2 (1529.0 nm) c) Yb3+: 2F5/2 → 2F7/2 (977.6 nm). While its low triplet energy level is ideally suited for efficient sensitization of Nd3+ and Er3+, the dppz ligand is considered not favorable as a sensitizer for most of the visible emitting lanthanide ions, due to its low-lying triplet level, which is too low for the accepting levels of most visible emitting lanthanides. Furthermore, the DNA intercalation ability of the [Nd(NO3)3(dppz)2] complex with calf thymus DNA (CT-DNA) was confirmed using fluorescence spectroscopy.
T2  - Molecules
T1  - DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2',3'-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction
VL  - 25
IS  - 22
SP  - 5309
DO  - 10.3390/molecules25225309
ER  - 
@article{
author = "Savić, Aleksandar and Kaczmarek, Anna M. and Van Deun, Rik and Van Hecke, Kristof",
year = "2020",
abstract = "In order to create near-infrared (NIR) luminescent lanthanide complexes suitable for DNA-interaction, novel lanthanide dppz complexes with general formula [Ln(NO3)3(dppz)2] (Ln = Nd3+, Er3+ and Yb3+; dppz = dipyrido[3,2-a:2',3'-c]phenazine) were synthesized, characterized and their luminescence properties were investigated. In addition, analogous compounds with other lanthanide ions (Ln = Ce3+, Pr3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Tm3+, Lu3+) were prepared. All complexes were characterized by IR spectroscopy and elemental analysis. Single-crystal X-ray diffraction analysis of the complexes (Ln = La3+, Ce3+, Pr3+, Nd3+, Eu3+, Er3+, Yb3+, Lu3+) showed that the lanthanide's first coordination sphere can be described as a bicapped dodecahedron, made up of two bidentate dppz ligands and three bidentate-coordinating nitrate anions. Efficient energy transfer was observed from the dppz ligand to the lanthanide ion (Nd3+, Er3+ and Yb3+), while relatively high luminescence lifetimes were detected for these complexes. In their excitation spectra, the maximum of the strong broad band is located at around 385 nm and this wavelength was further used for excitation of the chosen complexes. In their emission spectra, the following characteristic NIR emission peaks were observed: for a) Nd3+: 4F3/2 → 4I9/2 (870.8 nm), 4F3/2 → 4I11/2 (1052.7 nm) and 4F3/2 → 4I13/2 (1334.5 nm); b) Er3+: 4I13/2 → 4I15/2 (1529.0 nm) c) Yb3+: 2F5/2 → 2F7/2 (977.6 nm). While its low triplet energy level is ideally suited for efficient sensitization of Nd3+ and Er3+, the dppz ligand is considered not favorable as a sensitizer for most of the visible emitting lanthanide ions, due to its low-lying triplet level, which is too low for the accepting levels of most visible emitting lanthanides. Furthermore, the DNA intercalation ability of the [Nd(NO3)3(dppz)2] complex with calf thymus DNA (CT-DNA) was confirmed using fluorescence spectroscopy.",
journal = "Molecules",
title = "DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2',3'-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction",
volume = "25",
number = "22",
pages = "5309",
doi = "10.3390/molecules25225309"
}
Savić, A., Kaczmarek, A. M., Van Deun, R.,& Van Hecke, K.. (2020). DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2',3'-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction. in Molecules, 25(22), 5309.
https://doi.org/10.3390/molecules25225309
Savić A, Kaczmarek AM, Van Deun R, Van Hecke K. DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2',3'-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction. in Molecules. 2020;25(22):5309.
doi:10.3390/molecules25225309 .
Savić, Aleksandar, Kaczmarek, Anna M., Van Deun, Rik, Van Hecke, Kristof, "DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2',3'-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction" in Molecules, 25, no. 22 (2020):5309,
https://doi.org/10.3390/molecules25225309 . .
6
1
4
4

Ruthenium(II) bipyridine complexes: from synthesis and crystal structures to electrochemical and cytotoxicity investigation

Baroud, Afya A.; Mihajlović-Lalić, Ljiljana; Gligorijević, Nevenka; Aranđelović, Sandra; Stanković, Dalibor; Radulović, Siniša; Van Hecke, Kristof; Savić, Aleksandar; Grgurić-Šipka, Sanja

(Taylor & Francis Ltd, Abingdon, 2017)

TY  - JOUR
AU  - Baroud, Afya A.
AU  - Mihajlović-Lalić, Ljiljana
AU  - Gligorijević, Nevenka
AU  - Aranđelović, Sandra
AU  - Stanković, Dalibor
AU  - Radulović, Siniša
AU  - Van Hecke, Kristof
AU  - Savić, Aleksandar
AU  - Grgurić-Šipka, Sanja
PY  - 2017
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2423
AB  - Complexes 1-4, [Ru(L)(bpy)(2)]PF6, where bpy=2,2-bipyridine; HL=3-methylpyridine-2-carboxylic acid (HL1), 6-methylpyridine-2-carboxylic acid (HL2), 5-bromopyridine-2-carboxylic acid (HL3) and 6-bromopyridine-2-carboxylic acid (HL4), were synthesized and characterized. The electrochemical character of the complexes was investigated by cyclic voltammetry revealing two reversible reduction waves in the negative range of potentials, most likely due to a reduction of the bipyridine moiety. Cytotoxicity studies by MTT assay for 72h of drug action revealed that 2-4 exhibited moderate activity in cervical human tumor cells (HeLa). Complex 2 exhibited low activity in colon cancer LS-174 cells (180 +/- 10), while all complexes were devoid of activity in lung cancer A549 and non-tumor MRC-5 cells, up to 200M. Combinational studies of the most active complex 2, with pharmacological modulators of cell redox status, L-buthionine-sulfoximine (L-BSO) or N-acetyl-L-cysteine (NAC), showed that when L-BSO potentiated, 2 induced a sub-G1 peak of the cell cycle in the HeLa cell line. UV-vis and cyclic voltammetry were performed in order to investigate the binding mode of 2 to DNA and suggested intercalation for the complex-DNA interaction. [GRAPHICS]
PB  - Taylor & Francis Ltd, Abingdon
T2  - Journal of Coordination Chemistry
T1  - Ruthenium(II) bipyridine complexes: from synthesis and crystal structures to electrochemical and cytotoxicity investigation
VL  - 70
IS  - 5
SP  - 831
EP  - 847
DO  - 10.1080/00958972.2017.1282611
ER  - 
@article{
author = "Baroud, Afya A. and Mihajlović-Lalić, Ljiljana and Gligorijević, Nevenka and Aranđelović, Sandra and Stanković, Dalibor and Radulović, Siniša and Van Hecke, Kristof and Savić, Aleksandar and Grgurić-Šipka, Sanja",
year = "2017",
abstract = "Complexes 1-4, [Ru(L)(bpy)(2)]PF6, where bpy=2,2-bipyridine; HL=3-methylpyridine-2-carboxylic acid (HL1), 6-methylpyridine-2-carboxylic acid (HL2), 5-bromopyridine-2-carboxylic acid (HL3) and 6-bromopyridine-2-carboxylic acid (HL4), were synthesized and characterized. The electrochemical character of the complexes was investigated by cyclic voltammetry revealing two reversible reduction waves in the negative range of potentials, most likely due to a reduction of the bipyridine moiety. Cytotoxicity studies by MTT assay for 72h of drug action revealed that 2-4 exhibited moderate activity in cervical human tumor cells (HeLa). Complex 2 exhibited low activity in colon cancer LS-174 cells (180 +/- 10), while all complexes were devoid of activity in lung cancer A549 and non-tumor MRC-5 cells, up to 200M. Combinational studies of the most active complex 2, with pharmacological modulators of cell redox status, L-buthionine-sulfoximine (L-BSO) or N-acetyl-L-cysteine (NAC), showed that when L-BSO potentiated, 2 induced a sub-G1 peak of the cell cycle in the HeLa cell line. UV-vis and cyclic voltammetry were performed in order to investigate the binding mode of 2 to DNA and suggested intercalation for the complex-DNA interaction. [GRAPHICS]",
publisher = "Taylor & Francis Ltd, Abingdon",
journal = "Journal of Coordination Chemistry",
title = "Ruthenium(II) bipyridine complexes: from synthesis and crystal structures to electrochemical and cytotoxicity investigation",
volume = "70",
number = "5",
pages = "831-847",
doi = "10.1080/00958972.2017.1282611"
}
Baroud, A. A., Mihajlović-Lalić, L., Gligorijević, N., Aranđelović, S., Stanković, D., Radulović, S., Van Hecke, K., Savić, A.,& Grgurić-Šipka, S.. (2017). Ruthenium(II) bipyridine complexes: from synthesis and crystal structures to electrochemical and cytotoxicity investigation. in Journal of Coordination Chemistry
Taylor & Francis Ltd, Abingdon., 70(5), 831-847.
https://doi.org/10.1080/00958972.2017.1282611
Baroud AA, Mihajlović-Lalić L, Gligorijević N, Aranđelović S, Stanković D, Radulović S, Van Hecke K, Savić A, Grgurić-Šipka S. Ruthenium(II) bipyridine complexes: from synthesis and crystal structures to electrochemical and cytotoxicity investigation. in Journal of Coordination Chemistry. 2017;70(5):831-847.
doi:10.1080/00958972.2017.1282611 .
Baroud, Afya A., Mihajlović-Lalić, Ljiljana, Gligorijević, Nevenka, Aranđelović, Sandra, Stanković, Dalibor, Radulović, Siniša, Van Hecke, Kristof, Savić, Aleksandar, Grgurić-Šipka, Sanja, "Ruthenium(II) bipyridine complexes: from synthesis and crystal structures to electrochemical and cytotoxicity investigation" in Journal of Coordination Chemistry, 70, no. 5 (2017):831-847,
https://doi.org/10.1080/00958972.2017.1282611 . .
19
12
18
18

New ruthenium(II) bipyridyl complex: Synthesis, crystal structure and cytotoxicity

Baroud, Afya A.; Mihajlović-Lalić, Ljiljana; Stanković, Dalibor; Kajzerberger, Marijana; Van Hecke, Kristof; Grgurić-Šipka, Sanja; Savić, Aleksandar

(Serbian Chemical Soc, Belgrade, 2017)

TY  - JOUR
AU  - Baroud, Afya A.
AU  - Mihajlović-Lalić, Ljiljana
AU  - Stanković, Dalibor
AU  - Kajzerberger, Marijana
AU  - Van Hecke, Kristof
AU  - Grgurić-Šipka, Sanja
AU  - Savić, Aleksandar
PY  - 2017
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/2457
AB  - A new Ru(II) bipyridyl complex with O-4-hydrogenpyridine-2,4-dicarboxylate was synthesized and characterized by IR, NMR and mass spectrometry, X-ray diffraction analysis and elemental analysis. The electrochemical characteristics of the complex were investigated by cyclic voltammetry, revealing Ru(II)/Ru(III) electron transfer in the positive range of potentials. On the opposite potential side, multiple partially reversible peaks were dominant, representing subsequent reductions of the bulky bipyridyl moiety. The cytotoxic activity of the complex was tested in two human cancer cell lines: A549 (lung cancer) and K562 (leukemia) as well as non-tumor MRC-5 cells, by MTT assays. The IC50 values were  gt 300 and 177.63+/-2.28 mu M for the A549 and K562 cells, respectively.
PB  - Serbian Chemical Soc, Belgrade
T2  - Journal of the Serbian Chemical Society
T1  - New ruthenium(II) bipyridyl complex: Synthesis, crystal structure and cytotoxicity
VL  - 82
IS  - 3
SP  - 267
EP  - 275
DO  - 10.2298/JSC170109025B
ER  - 
@article{
author = "Baroud, Afya A. and Mihajlović-Lalić, Ljiljana and Stanković, Dalibor and Kajzerberger, Marijana and Van Hecke, Kristof and Grgurić-Šipka, Sanja and Savić, Aleksandar",
year = "2017",
abstract = "A new Ru(II) bipyridyl complex with O-4-hydrogenpyridine-2,4-dicarboxylate was synthesized and characterized by IR, NMR and mass spectrometry, X-ray diffraction analysis and elemental analysis. The electrochemical characteristics of the complex were investigated by cyclic voltammetry, revealing Ru(II)/Ru(III) electron transfer in the positive range of potentials. On the opposite potential side, multiple partially reversible peaks were dominant, representing subsequent reductions of the bulky bipyridyl moiety. The cytotoxic activity of the complex was tested in two human cancer cell lines: A549 (lung cancer) and K562 (leukemia) as well as non-tumor MRC-5 cells, by MTT assays. The IC50 values were  gt 300 and 177.63+/-2.28 mu M for the A549 and K562 cells, respectively.",
publisher = "Serbian Chemical Soc, Belgrade",
journal = "Journal of the Serbian Chemical Society",
title = "New ruthenium(II) bipyridyl complex: Synthesis, crystal structure and cytotoxicity",
volume = "82",
number = "3",
pages = "267-275",
doi = "10.2298/JSC170109025B"
}
Baroud, A. A., Mihajlović-Lalić, L., Stanković, D., Kajzerberger, M., Van Hecke, K., Grgurić-Šipka, S.,& Savić, A.. (2017). New ruthenium(II) bipyridyl complex: Synthesis, crystal structure and cytotoxicity. in Journal of the Serbian Chemical Society
Serbian Chemical Soc, Belgrade., 82(3), 267-275.
https://doi.org/10.2298/JSC170109025B
Baroud AA, Mihajlović-Lalić L, Stanković D, Kajzerberger M, Van Hecke K, Grgurić-Šipka S, Savić A. New ruthenium(II) bipyridyl complex: Synthesis, crystal structure and cytotoxicity. in Journal of the Serbian Chemical Society. 2017;82(3):267-275.
doi:10.2298/JSC170109025B .
Baroud, Afya A., Mihajlović-Lalić, Ljiljana, Stanković, Dalibor, Kajzerberger, Marijana, Van Hecke, Kristof, Grgurić-Šipka, Sanja, Savić, Aleksandar, "New ruthenium(II) bipyridyl complex: Synthesis, crystal structure and cytotoxicity" in Journal of the Serbian Chemical Society, 82, no. 3 (2017):267-275,
https://doi.org/10.2298/JSC170109025B . .
1
4
4
4
4

Supplementary data for article: Baroud, A. A.; Mihajlović-Lalić, L. E.; Gligorijević, N.; Aranđelović, S.; Stanković, D.; Radulović, S.; Van Hecke, K.; Savić, A.; Grgurić-Šipka, S. Ruthenium(II) Bipyridine Complexes: From Synthesis and Crystal Structures to Electrochemical and Cytotoxicity Investigation. Journal of Coordination Chemistry 2017, 70 (5), 831–847. https://doi.org/10.1080/00958972.2017.1282611

Baroud, Afya A.; Mihajlović-Lalić, Ljiljana; Gligorijević, Nevenka; Aranđelović, Sandra; Stanković, Dalibor; Radulović, Siniša; Van Hecke, Kristof; Savić, Aleksandar; Grgurić-Šipka, Sanja

(Taylor & Francis Ltd, Abingdon, 2017)

TY  - DATA
AU  - Baroud, Afya A.
AU  - Mihajlović-Lalić, Ljiljana
AU  - Gligorijević, Nevenka
AU  - Aranđelović, Sandra
AU  - Stanković, Dalibor
AU  - Radulović, Siniša
AU  - Van Hecke, Kristof
AU  - Savić, Aleksandar
AU  - Grgurić-Šipka, Sanja
PY  - 2017
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/3138
PB  - Taylor & Francis Ltd, Abingdon
T2  - Journal of Coordination Chemistry
T1  - Supplementary data for article:  Baroud, A. A.; Mihajlović-Lalić, L. E.; Gligorijević, N.; Aranđelović, S.; Stanković, D.; Radulović, S.; Van Hecke, K.; Savić, A.; Grgurić-Šipka, S. Ruthenium(II) Bipyridine Complexes: From Synthesis and Crystal Structures to Electrochemical and Cytotoxicity Investigation. Journal of Coordination Chemistry 2017, 70 (5), 831–847. https://doi.org/10.1080/00958972.2017.1282611
UR  - https://hdl.handle.net/21.15107/rcub_cherry_3138
ER  - 
@misc{
author = "Baroud, Afya A. and Mihajlović-Lalić, Ljiljana and Gligorijević, Nevenka and Aranđelović, Sandra and Stanković, Dalibor and Radulović, Siniša and Van Hecke, Kristof and Savić, Aleksandar and Grgurić-Šipka, Sanja",
year = "2017",
publisher = "Taylor & Francis Ltd, Abingdon",
journal = "Journal of Coordination Chemistry",
title = "Supplementary data for article:  Baroud, A. A.; Mihajlović-Lalić, L. E.; Gligorijević, N.; Aranđelović, S.; Stanković, D.; Radulović, S.; Van Hecke, K.; Savić, A.; Grgurić-Šipka, S. Ruthenium(II) Bipyridine Complexes: From Synthesis and Crystal Structures to Electrochemical and Cytotoxicity Investigation. Journal of Coordination Chemistry 2017, 70 (5), 831–847. https://doi.org/10.1080/00958972.2017.1282611",
url = "https://hdl.handle.net/21.15107/rcub_cherry_3138"
}
Baroud, A. A., Mihajlović-Lalić, L., Gligorijević, N., Aranđelović, S., Stanković, D., Radulović, S., Van Hecke, K., Savić, A.,& Grgurić-Šipka, S.. (2017). Supplementary data for article:  Baroud, A. A.; Mihajlović-Lalić, L. E.; Gligorijević, N.; Aranđelović, S.; Stanković, D.; Radulović, S.; Van Hecke, K.; Savić, A.; Grgurić-Šipka, S. Ruthenium(II) Bipyridine Complexes: From Synthesis and Crystal Structures to Electrochemical and Cytotoxicity Investigation. Journal of Coordination Chemistry 2017, 70 (5), 831–847. https://doi.org/10.1080/00958972.2017.1282611. in Journal of Coordination Chemistry
Taylor & Francis Ltd, Abingdon..
https://hdl.handle.net/21.15107/rcub_cherry_3138
Baroud AA, Mihajlović-Lalić L, Gligorijević N, Aranđelović S, Stanković D, Radulović S, Van Hecke K, Savić A, Grgurić-Šipka S. Supplementary data for article:  Baroud, A. A.; Mihajlović-Lalić, L. E.; Gligorijević, N.; Aranđelović, S.; Stanković, D.; Radulović, S.; Van Hecke, K.; Savić, A.; Grgurić-Šipka, S. Ruthenium(II) Bipyridine Complexes: From Synthesis and Crystal Structures to Electrochemical and Cytotoxicity Investigation. Journal of Coordination Chemistry 2017, 70 (5), 831–847. https://doi.org/10.1080/00958972.2017.1282611. in Journal of Coordination Chemistry. 2017;.
https://hdl.handle.net/21.15107/rcub_cherry_3138 .
Baroud, Afya A., Mihajlović-Lalić, Ljiljana, Gligorijević, Nevenka, Aranđelović, Sandra, Stanković, Dalibor, Radulović, Siniša, Van Hecke, Kristof, Savić, Aleksandar, Grgurić-Šipka, Sanja, "Supplementary data for article:  Baroud, A. A.; Mihajlović-Lalić, L. E.; Gligorijević, N.; Aranđelović, S.; Stanković, D.; Radulović, S.; Van Hecke, K.; Savić, A.; Grgurić-Šipka, S. Ruthenium(II) Bipyridine Complexes: From Synthesis and Crystal Structures to Electrochemical and Cytotoxicity Investigation. Journal of Coordination Chemistry 2017, 70 (5), 831–847. https://doi.org/10.1080/00958972.2017.1282611" in Journal of Coordination Chemistry (2017),
https://hdl.handle.net/21.15107/rcub_cherry_3138 .

Supplementary data for article: Van Deun, R.; D’Hooge, M.; Savic, A.; Van Driessche, I.; Van Hecke, K.; Kaczmarek, A. M. Influence of Y3+, Gd3+, and Lu3+ Co-Doping on the Phase and Luminescence Properties of Monoclinic Eu:LaVO4 Particles. Dalton Transactions 2015, 44 (42), 18418–18426. https://doi.org/10.1039/c5dt03147h

Van Deun, Rik; D'hooge, Micheline; Savić, Aleksandar; Van Driessche, Isabel; Van Hecke, Kristof; Kaczmarek, Anna M.

(Royal Soc Chemistry, Cambridge, 2015)

TY  - DATA
AU  - Van Deun, Rik
AU  - D'hooge, Micheline
AU  - Savić, Aleksandar
AU  - Van Driessche, Isabel
AU  - Van Hecke, Kristof
AU  - Kaczmarek, Anna M.
PY  - 2015
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/3380
PB  - Royal Soc Chemistry, Cambridge
T2  - Dalton Transactions
T1  - Supplementary data for article: Van Deun, R.; D’Hooge, M.; Savic, A.; Van Driessche, I.; Van Hecke, K.; Kaczmarek, A. M. Influence of Y3+, Gd3+, and Lu3+ Co-Doping on the Phase and Luminescence Properties of Monoclinic Eu:LaVO4 Particles. Dalton Transactions 2015, 44 (42), 18418–18426. https://doi.org/10.1039/c5dt03147h
UR  - https://hdl.handle.net/21.15107/rcub_cherry_3380
ER  - 
@misc{
author = "Van Deun, Rik and D'hooge, Micheline and Savić, Aleksandar and Van Driessche, Isabel and Van Hecke, Kristof and Kaczmarek, Anna M.",
year = "2015",
publisher = "Royal Soc Chemistry, Cambridge",
journal = "Dalton Transactions",
title = "Supplementary data for article: Van Deun, R.; D’Hooge, M.; Savic, A.; Van Driessche, I.; Van Hecke, K.; Kaczmarek, A. M. Influence of Y3+, Gd3+, and Lu3+ Co-Doping on the Phase and Luminescence Properties of Monoclinic Eu:LaVO4 Particles. Dalton Transactions 2015, 44 (42), 18418–18426. https://doi.org/10.1039/c5dt03147h",
url = "https://hdl.handle.net/21.15107/rcub_cherry_3380"
}
Van Deun, R., D'hooge, M., Savić, A., Van Driessche, I., Van Hecke, K.,& Kaczmarek, A. M.. (2015). Supplementary data for article: Van Deun, R.; D’Hooge, M.; Savic, A.; Van Driessche, I.; Van Hecke, K.; Kaczmarek, A. M. Influence of Y3+, Gd3+, and Lu3+ Co-Doping on the Phase and Luminescence Properties of Monoclinic Eu:LaVO4 Particles. Dalton Transactions 2015, 44 (42), 18418–18426. https://doi.org/10.1039/c5dt03147h. in Dalton Transactions
Royal Soc Chemistry, Cambridge..
https://hdl.handle.net/21.15107/rcub_cherry_3380
Van Deun R, D'hooge M, Savić A, Van Driessche I, Van Hecke K, Kaczmarek AM. Supplementary data for article: Van Deun, R.; D’Hooge, M.; Savic, A.; Van Driessche, I.; Van Hecke, K.; Kaczmarek, A. M. Influence of Y3+, Gd3+, and Lu3+ Co-Doping on the Phase and Luminescence Properties of Monoclinic Eu:LaVO4 Particles. Dalton Transactions 2015, 44 (42), 18418–18426. https://doi.org/10.1039/c5dt03147h. in Dalton Transactions. 2015;.
https://hdl.handle.net/21.15107/rcub_cherry_3380 .
Van Deun, Rik, D'hooge, Micheline, Savić, Aleksandar, Van Driessche, Isabel, Van Hecke, Kristof, Kaczmarek, Anna M., "Supplementary data for article: Van Deun, R.; D’Hooge, M.; Savic, A.; Van Driessche, I.; Van Hecke, K.; Kaczmarek, A. M. Influence of Y3+, Gd3+, and Lu3+ Co-Doping on the Phase and Luminescence Properties of Monoclinic Eu:LaVO4 Particles. Dalton Transactions 2015, 44 (42), 18418–18426. https://doi.org/10.1039/c5dt03147h" in Dalton Transactions (2015),
https://hdl.handle.net/21.15107/rcub_cherry_3380 .

Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles

Van Deun, Rik; D'hooge, Micheline; Savić, Aleksandar; Van Driessche, Isabel; Van Hecke, Kristof; Kaczmarek, Anna M.

(Royal Soc Chemistry, Cambridge, 2015)

TY  - JOUR
AU  - Van Deun, Rik
AU  - D'hooge, Micheline
AU  - Savić, Aleksandar
AU  - Van Driessche, Isabel
AU  - Van Hecke, Kristof
AU  - Kaczmarek, Anna M.
PY  - 2015
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/3379
AB  - Nano-sized particles of monoclinic-LaVO4 were prepared in a short reaction time of 30 minutes by employing a microwave assisted hydrothermal synthesis in the presence of glycerol, which was used both as a solvent and structure-directing agent. The tetragonal-LaVO4 is known to show strong luminescence properties when doped with Ln(3+), whereas the monoclinic-LaVO4 is usually considered not suitable for luminescence and therefore luminescence properties of monoclinic-LaVO4 doped with Ln(3+) ions are seldom investigated. Due to the scarce amount of research on the topic of luminescence of Ln(3+) doped monoclinic-LaVO4 in this paper a detailed study of solid state luminescence properties, including quantum yields, of nano-sized monoclinic-LaVO4 doped with different molar percentages of Eu3+ is presented. It was observed that the 12.5% Eu3+ doped sample showed the strongest luminescence properties. Additionally a study of the influence of different rare-earth ions (Y3+, Gd3+, Lu3+) co-doped into the particles was performed in order to explore the potential of increasing the luminescence of these materials. Furthermore stable colloidal suspensions of the Eu3+ doped monoclinic-LaVO4 nanoparticles showing strong red emission could be obtained.
PB  - Royal Soc Chemistry, Cambridge
T2  - Dalton Transactions
T1  - Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles
VL  - 44
IS  - 42
SP  - 18418
EP  - 18426
DO  - 10.1039/c5dt03147h
ER  - 
@article{
author = "Van Deun, Rik and D'hooge, Micheline and Savić, Aleksandar and Van Driessche, Isabel and Van Hecke, Kristof and Kaczmarek, Anna M.",
year = "2015",
abstract = "Nano-sized particles of monoclinic-LaVO4 were prepared in a short reaction time of 30 minutes by employing a microwave assisted hydrothermal synthesis in the presence of glycerol, which was used both as a solvent and structure-directing agent. The tetragonal-LaVO4 is known to show strong luminescence properties when doped with Ln(3+), whereas the monoclinic-LaVO4 is usually considered not suitable for luminescence and therefore luminescence properties of monoclinic-LaVO4 doped with Ln(3+) ions are seldom investigated. Due to the scarce amount of research on the topic of luminescence of Ln(3+) doped monoclinic-LaVO4 in this paper a detailed study of solid state luminescence properties, including quantum yields, of nano-sized monoclinic-LaVO4 doped with different molar percentages of Eu3+ is presented. It was observed that the 12.5% Eu3+ doped sample showed the strongest luminescence properties. Additionally a study of the influence of different rare-earth ions (Y3+, Gd3+, Lu3+) co-doped into the particles was performed in order to explore the potential of increasing the luminescence of these materials. Furthermore stable colloidal suspensions of the Eu3+ doped monoclinic-LaVO4 nanoparticles showing strong red emission could be obtained.",
publisher = "Royal Soc Chemistry, Cambridge",
journal = "Dalton Transactions",
title = "Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles",
volume = "44",
number = "42",
pages = "18418-18426",
doi = "10.1039/c5dt03147h"
}
Van Deun, R., D'hooge, M., Savić, A., Van Driessche, I., Van Hecke, K.,& Kaczmarek, A. M.. (2015). Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles. in Dalton Transactions
Royal Soc Chemistry, Cambridge., 44(42), 18418-18426.
https://doi.org/10.1039/c5dt03147h
Van Deun R, D'hooge M, Savić A, Van Driessche I, Van Hecke K, Kaczmarek AM. Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles. in Dalton Transactions. 2015;44(42):18418-18426.
doi:10.1039/c5dt03147h .
Van Deun, Rik, D'hooge, Micheline, Savić, Aleksandar, Van Driessche, Isabel, Van Hecke, Kristof, Kaczmarek, Anna M., "Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles" in Dalton Transactions, 44, no. 42 (2015):18418-18426,
https://doi.org/10.1039/c5dt03147h . .
1
29
22
29
28

Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles

Van Deun, Rik; D'hooge, Micheline; Savić, Aleksandar; Van Driessche, Isabel; Van Hecke, Kristof; Kaczmarek, Anna M.

(Royal Soc Chemistry, Cambridge, 2015)

TY  - JOUR
AU  - Van Deun, Rik
AU  - D'hooge, Micheline
AU  - Savić, Aleksandar
AU  - Van Driessche, Isabel
AU  - Van Hecke, Kristof
AU  - Kaczmarek, Anna M.
PY  - 2015
UR  - https://cherry.chem.bg.ac.rs/handle/123456789/1988
AB  - Nano-sized particles of monoclinic-LaVO4 were prepared in a short reaction time of 30 minutes by employing a microwave assisted hydrothermal synthesis in the presence of glycerol, which was used both as a solvent and structure-directing agent. The tetragonal-LaVO4 is known to show strong luminescence properties when doped with Ln(3+), whereas the monoclinic-LaVO4 is usually considered not suitable for luminescence and therefore luminescence properties of monoclinic-LaVO4 doped with Ln(3+) ions are seldom investigated. Due to the scarce amount of research on the topic of luminescence of Ln(3+) doped monoclinic-LaVO4 in this paper a detailed study of solid state luminescence properties, including quantum yields, of nano-sized monoclinic-LaVO4 doped with different molar percentages of Eu3+ is presented. It was observed that the 12.5% Eu3+ doped sample showed the strongest luminescence properties. Additionally a study of the influence of different rare-earth ions (Y3+, Gd3+, Lu3+) co-doped into the particles was performed in order to explore the potential of increasing the luminescence of these materials. Furthermore stable colloidal suspensions of the Eu3+ doped monoclinic-LaVO4 nanoparticles showing strong red emission could be obtained.
PB  - Royal Soc Chemistry, Cambridge
T2  - Dalton Transactions
T1  - Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles
VL  - 44
IS  - 42
SP  - 18418
EP  - 18426
DO  - 10.1039/c5dt03147h
ER  - 
@article{
author = "Van Deun, Rik and D'hooge, Micheline and Savić, Aleksandar and Van Driessche, Isabel and Van Hecke, Kristof and Kaczmarek, Anna M.",
year = "2015",
abstract = "Nano-sized particles of monoclinic-LaVO4 were prepared in a short reaction time of 30 minutes by employing a microwave assisted hydrothermal synthesis in the presence of glycerol, which was used both as a solvent and structure-directing agent. The tetragonal-LaVO4 is known to show strong luminescence properties when doped with Ln(3+), whereas the monoclinic-LaVO4 is usually considered not suitable for luminescence and therefore luminescence properties of monoclinic-LaVO4 doped with Ln(3+) ions are seldom investigated. Due to the scarce amount of research on the topic of luminescence of Ln(3+) doped monoclinic-LaVO4 in this paper a detailed study of solid state luminescence properties, including quantum yields, of nano-sized monoclinic-LaVO4 doped with different molar percentages of Eu3+ is presented. It was observed that the 12.5% Eu3+ doped sample showed the strongest luminescence properties. Additionally a study of the influence of different rare-earth ions (Y3+, Gd3+, Lu3+) co-doped into the particles was performed in order to explore the potential of increasing the luminescence of these materials. Furthermore stable colloidal suspensions of the Eu3+ doped monoclinic-LaVO4 nanoparticles showing strong red emission could be obtained.",
publisher = "Royal Soc Chemistry, Cambridge",
journal = "Dalton Transactions",
title = "Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles",
volume = "44",
number = "42",
pages = "18418-18426",
doi = "10.1039/c5dt03147h"
}
Van Deun, R., D'hooge, M., Savić, A., Van Driessche, I., Van Hecke, K.,& Kaczmarek, A. M.. (2015). Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles. in Dalton Transactions
Royal Soc Chemistry, Cambridge., 44(42), 18418-18426.
https://doi.org/10.1039/c5dt03147h
Van Deun R, D'hooge M, Savić A, Van Driessche I, Van Hecke K, Kaczmarek AM. Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles. in Dalton Transactions. 2015;44(42):18418-18426.
doi:10.1039/c5dt03147h .
Van Deun, Rik, D'hooge, Micheline, Savić, Aleksandar, Van Driessche, Isabel, Van Hecke, Kristof, Kaczmarek, Anna M., "Influence of Y3+, Gd3+, and Lu3+ co-doping on the phase and luminescence properties of monoclinic Eu:LaVO4 particles" in Dalton Transactions, 44, no. 42 (2015):18418-18426,
https://doi.org/10.1039/c5dt03147h . .
1
29
22
29
28